The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based 18F-FDG PET/CT study

BMC Cardiovasc Disord. 2018 Oct 29;18(1):203. doi: 10.1186/s12872-018-0943-9.

Abstract

Background: In diabetes, dysregulated substrate utilization and energy metabolism of myocardium can lead to heart failure. To examine the dynamic changes of myocardium, most of the previous studies conducted dynamic myocardial PET imaging following euglycemic-hyperinsulinemic clamp, which involves complicated procedures. In comparison, the whole-body 18F-FDG PET/CT scan is a simple and widely used method. Therefore, we hope to use this method to observe abnormal myocardial glucose metabolism in diabetes and determine the influencing factors.

Methods: We retrospectively analyzed PET/CT images of 191 subjects from our medical examination center. The levels of FDG uptake in myocardium were visually divided into 4 grades (Grade 0-3, from low to high). The differences in clinical and metabolic parameters among diabetes mellitus (DM), impaired fasting glucose (IFG), and normal fasting glucose (NFG) groups were analyzed, as well as their associations with myocardial FDG uptake.

Results: Compared with NFG and IFG groups, DM group had more cardiovascular-related risk factors. The degree of myocardial FDG uptake was significantly decreased in DM group; when myocardial FDG uptake ≤ Grade 1, the sensitivity of DM prediction was 84.0%, and the specificity was 58.4%. Univariate analysis showed that the myocardial FDG uptake was weakly and negatively correlated with multiple metabolic-related parameters (r = - 0.173~ - 0.365, P < 0.05). Multivariate logistic regression analysis showed that gender (male), HOMA-IR and nonalcoholic fatty liver disease (NAFLD) were independent risk factors for poor myocardial FDG uptake.

Conclusions: Diabetes is associated with decreased myocardial glucose metabolism, which is mediated by multiple metabolic abnormalities.

Keywords: Diabetes mellitus; FDG; Insulin resistance; Nonalcoholic fatty liver disease; PET.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Glucose / metabolism*
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / diagnostic imaging*
  • Diabetic Cardiomyopathies / blood
  • Diabetic Cardiomyopathies / diagnostic imaging*
  • Diabetic Cardiomyopathies / etiology
  • Fasting / blood
  • Feasibility Studies
  • Female
  • Fluorodeoxyglucose F18 / administration & dosage*
  • Humans
  • Insulin Resistance
  • Male
  • Middle Aged
  • Myocardium / metabolism*
  • Non-alcoholic Fatty Liver Disease / complications
  • Non-alcoholic Fatty Liver Disease / diagnostic imaging
  • Non-alcoholic Fatty Liver Disease / metabolism
  • Positron Emission Tomography Computed Tomography*
  • Predictive Value of Tests
  • Radiopharmaceuticals / administration & dosage*
  • Retrospective Studies
  • Risk Factors
  • Sex Factors
  • Whole Body Imaging

Substances

  • Blood Glucose
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18